HomeBCTX • NASDAQ
add
Briacell Therapeutics Corp
Previous close
$0.91
Day range
$0.85 - $0.94
Year range
$0.85 - $7.59
Market cap
22.85M CAD
Avg Volume
113.32K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Apr 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.23M | 62.58% |
Net income | 1.72M | 135.05% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.23M | -62.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Apr 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 935.69K | -96.68% |
Total assets | 6.20M | -79.13% |
Total liabilities | 12.44M | -65.08% |
Total equity | -6.23M | — |
Shares outstanding | 18.28M | — |
Price to book | -2.46 | — |
Return on assets | -250.34% | — |
Return on capital | 317.16% | — |
Cash Flow
Net change in cash
(USD) | Apr 2024info | Y/Y change |
---|---|---|
Net income | 1.72M | 135.05% |
Cash from operations | -5.08M | 4.65% |
Cash from investing | -225.00K | — |
Cash from financing | — | — |
Net change in cash | -5.31M | 0.40% |
Free cash flow | -1.64M | 52.51% |
About
Founded
2006
Headquarters
Website
Employees
16